HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 01-DEC-03 1VH6 TITLE CRYSTAL STRUCTURE OF A FLAGELLAR PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: FLAGELLAR PROTEIN FLIS; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 GENE: FLIS, BSU35330; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS STRUCTURAL GENOMICS, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR STRUCTURAL GENOMIX REVDAT 6 27-DEC-23 1VH6 1 LINK REVDAT 5 04-OCT-17 1VH6 1 REMARK REVDAT 4 13-JUL-11 1VH6 1 VERSN REVDAT 3 24-FEB-09 1VH6 1 VERSN REVDAT 2 30-AUG-05 1VH6 1 JRNL REVDAT 1 30-DEC-03 1VH6 0 JRNL AUTH J.BADGER,J.M.SAUDER,J.M.ADAMS,S.ANTONYSAMY,K.BAIN, JRNL AUTH 2 M.G.BERGSEID,S.G.BUCHANAN,M.D.BUCHANAN,Y.BATIYENKO, JRNL AUTH 3 J.A.CHRISTOPHER,S.EMTAGE,A.EROSHKINA,I.FEIL,E.B.FURLONG, JRNL AUTH 4 K.S.GAJIWALA,X.GAO,D.HE,J.HENDLE,A.HUBER,K.HODA,P.KEARINS, JRNL AUTH 5 C.KISSINGER,B.LAUBERT,H.A.LEWIS,J.LIN,K.LOOMIS,D.LORIMER, JRNL AUTH 6 G.LOUIE,M.MALETIC,C.D.MARSH,I.MILLER,J.MOLINARI, JRNL AUTH 7 H.J.MULLER-DIECKMANN,J.M.NEWMAN,B.W.NOLAND,B.PAGARIGAN, JRNL AUTH 8 F.PARK,T.S.PEAT,K.W.POST,S.RADOJICIC,A.RAMOS,R.ROMERO, JRNL AUTH 9 M.E.RUTTER,W.E.SANDERSON,K.D.SCHWINN,J.TRESSER,J.WINHOVEN, JRNL AUTH10 T.A.WRIGHT,L.WU,J.XU,T.J.HARRIS JRNL TITL STRUCTURAL ANALYSIS OF A SET OF PROTEINS RESULTING FROM A JRNL TITL 2 BACTERIAL GENOMICS PROJECT JRNL REF PROTEINS V. 60 787 2005 JRNL REFN ISSN 0887-3585 JRNL PMID 16021622 JRNL DOI 10.1002/PROT.20541 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 4.0 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 8654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 861 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 12 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.83900 REMARK 3 B22 (A**2) : 2.54600 REMARK 3 B33 (A**2) : -0.70700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.007 ; NULL REMARK 3 ANGLE DISTANCE (A) : 1.223 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.005 ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.084 ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 0.928 ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.939 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.822 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 2.117 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.107 ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VH6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000001865. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA, TRUNCATE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8657 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 46.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SE-MET SAD PHASING REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.98400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.28050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.07550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.28050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.98400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.07550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -1 REMARK 465 SER A 0 REMARK 465 LEU A 1 REMARK 465 ALA A 2 REMARK 465 ILE A 3 REMARK 465 GLN A 4 REMARK 465 ASN A 5 REMARK 465 PRO A 6 REMARK 465 TYR A 7 REMARK 465 THR A 8 REMARK 465 ALA A 9 REMARK 465 TYR A 10 REMARK 465 GLN A 11 REMARK 465 GLN A 12 REMARK 465 ASN A 13 REMARK 465 SER A 14 REMARK 465 VAL A 15 REMARK 465 ASN A 16 REMARK 465 THR A 17 REMARK 465 GLN A 120 REMARK 465 SER A 121 REMARK 465 GLU A 122 REMARK 465 ARG A 123 REMARK 465 LYS A 124 REMARK 465 ASP A 125 REMARK 465 ARG A 126 REMARK 465 HIS A 127 REMARK 465 GLY A 128 REMARK 465 SER A 129 REMARK 465 GLY A 130 REMARK 465 GLY A 131 REMARK 465 ILE A 132 REMARK 465 ALA A 133 REMARK 465 GLU A 134 REMARK 465 GLY A 135 REMARK 465 GLY A 136 REMARK 465 SER A 137 REMARK 465 HIS A 138 REMARK 465 HIS A 139 REMARK 465 HIS A 140 REMARK 465 HIS A 141 REMARK 465 HIS A 142 REMARK 465 HIS A 143 REMARK 465 MSE B -1 REMARK 465 SER B 0 REMARK 465 LEU B 1 REMARK 465 ALA B 2 REMARK 465 ILE B 3 REMARK 465 GLN B 4 REMARK 465 ASN B 5 REMARK 465 PRO B 6 REMARK 465 TYR B 7 REMARK 465 THR B 8 REMARK 465 ALA B 9 REMARK 465 TYR B 10 REMARK 465 GLN B 11 REMARK 465 GLN B 12 REMARK 465 ASN B 13 REMARK 465 SER B 14 REMARK 465 ARG B 123 REMARK 465 LYS B 124 REMARK 465 ASP B 125 REMARK 465 ARG B 126 REMARK 465 HIS B 127 REMARK 465 GLY B 128 REMARK 465 SER B 129 REMARK 465 GLY B 130 REMARK 465 GLY B 131 REMARK 465 ILE B 132 REMARK 465 ALA B 133 REMARK 465 GLU B 134 REMARK 465 GLY B 135 REMARK 465 GLY B 136 REMARK 465 SER B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 HIS B 141 REMARK 465 HIS B 142 REMARK 465 HIS B 143 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 52 CD OE1 OE2 REMARK 470 GLN A 117 CD OE1 NE2 REMARK 470 GLU B 48 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 75 176.58 66.90 REMARK 500 SER B 75 -174.62 56.67 REMARK 500 SER B 121 14.84 -52.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 1VH6 A 2 133 UNP P39739 FLIS_BACSU 2 133 DBREF 1VH6 B 2 133 UNP P39739 FLIS_BACSU 2 133 SEQADV 1VH6 MSE A -1 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 SER A 0 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 LEU A 1 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 MSE A 26 UNP P39739 MET 26 MODIFIED RESIDUE SEQADV 1VH6 MSE A 47 UNP P39739 MET 47 MODIFIED RESIDUE SEQADV 1VH6 MSE A 78 UNP P39739 MET 78 MODIFIED RESIDUE SEQADV 1VH6 MSE A 81 UNP P39739 MET 81 MODIFIED RESIDUE SEQADV 1VH6 MSE A 85 UNP P39739 MET 85 MODIFIED RESIDUE SEQADV 1VH6 MSE A 100 UNP P39739 MET 100 MODIFIED RESIDUE SEQADV 1VH6 GLU A 134 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 GLY A 135 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 GLY A 136 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 SER A 137 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 138 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 139 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 140 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 141 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 142 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS A 143 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 MSE B -1 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 SER B 0 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 LEU B 1 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 MSE B 26 UNP P39739 MET 26 MODIFIED RESIDUE SEQADV 1VH6 MSE B 47 UNP P39739 MET 47 MODIFIED RESIDUE SEQADV 1VH6 MSE B 78 UNP P39739 MET 78 MODIFIED RESIDUE SEQADV 1VH6 MSE B 81 UNP P39739 MET 81 MODIFIED RESIDUE SEQADV 1VH6 MSE B 85 UNP P39739 MET 85 MODIFIED RESIDUE SEQADV 1VH6 MSE B 100 UNP P39739 MET 100 MODIFIED RESIDUE SEQADV 1VH6 GLU B 134 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 GLY B 135 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 GLY B 136 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 SER B 137 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 138 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 139 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 140 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 141 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 142 UNP P39739 CLONING ARTIFACT SEQADV 1VH6 HIS B 143 UNP P39739 CLONING ARTIFACT SEQRES 1 A 145 MSE SER LEU ALA ILE GLN ASN PRO TYR THR ALA TYR GLN SEQRES 2 A 145 GLN ASN SER VAL ASN THR ALA THR PRO GLY GLU LEU THR SEQRES 3 A 145 LEU MSE LEU TYR ASN GLY CYS LEU LYS PHE ILE ARG LEU SEQRES 4 A 145 ALA ALA GLN ALA ILE GLU ASN ASP ASP MSE GLU ARG LYS SEQRES 5 A 145 ASN GLU ASN LEU ILE LYS ALA GLN ASN ILE ILE GLN GLU SEQRES 6 A 145 LEU ASN PHE THR LEU ASN ARG ASN ILE GLU LEU SER ALA SEQRES 7 A 145 SER MSE GLY ALA MSE TYR ASP TYR MSE TYR ARG ARG LEU SEQRES 8 A 145 VAL GLN ALA ASN ILE LYS ASN ASP THR GLY MSE LEU ALA SEQRES 9 A 145 GLU VAL GLU GLY TYR VAL THR ASP PHE ARG ASP ALA TRP SEQRES 10 A 145 LYS GLN ALA ILE GLN SER GLU ARG LYS ASP ARG HIS GLY SEQRES 11 A 145 SER GLY GLY ILE ALA GLU GLY GLY SER HIS HIS HIS HIS SEQRES 12 A 145 HIS HIS SEQRES 1 B 145 MSE SER LEU ALA ILE GLN ASN PRO TYR THR ALA TYR GLN SEQRES 2 B 145 GLN ASN SER VAL ASN THR ALA THR PRO GLY GLU LEU THR SEQRES 3 B 145 LEU MSE LEU TYR ASN GLY CYS LEU LYS PHE ILE ARG LEU SEQRES 4 B 145 ALA ALA GLN ALA ILE GLU ASN ASP ASP MSE GLU ARG LYS SEQRES 5 B 145 ASN GLU ASN LEU ILE LYS ALA GLN ASN ILE ILE GLN GLU SEQRES 6 B 145 LEU ASN PHE THR LEU ASN ARG ASN ILE GLU LEU SER ALA SEQRES 7 B 145 SER MSE GLY ALA MSE TYR ASP TYR MSE TYR ARG ARG LEU SEQRES 8 B 145 VAL GLN ALA ASN ILE LYS ASN ASP THR GLY MSE LEU ALA SEQRES 9 B 145 GLU VAL GLU GLY TYR VAL THR ASP PHE ARG ASP ALA TRP SEQRES 10 B 145 LYS GLN ALA ILE GLN SER GLU ARG LYS ASP ARG HIS GLY SEQRES 11 B 145 SER GLY GLY ILE ALA GLU GLY GLY SER HIS HIS HIS HIS SEQRES 12 B 145 HIS HIS MODRES 1VH6 MSE A 26 MET SELENOMETHIONINE MODRES 1VH6 MSE A 47 MET SELENOMETHIONINE MODRES 1VH6 MSE A 78 MET SELENOMETHIONINE MODRES 1VH6 MSE A 81 MET SELENOMETHIONINE MODRES 1VH6 MSE A 85 MET SELENOMETHIONINE MODRES 1VH6 MSE A 100 MET SELENOMETHIONINE MODRES 1VH6 MSE B 26 MET SELENOMETHIONINE MODRES 1VH6 MSE B 47 MET SELENOMETHIONINE MODRES 1VH6 MSE B 78 MET SELENOMETHIONINE MODRES 1VH6 MSE B 81 MET SELENOMETHIONINE MODRES 1VH6 MSE B 85 MET SELENOMETHIONINE MODRES 1VH6 MSE B 100 MET SELENOMETHIONINE HET MSE A 26 8 HET MSE A 47 8 HET MSE A 78 8 HET MSE A 81 8 HET MSE A 85 8 HET MSE A 100 8 HET MSE B 26 8 HET MSE B 47 8 HET MSE B 78 8 HET MSE B 81 8 HET MSE B 85 11 HET MSE B 100 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 HOH *12(H2 O) HELIX 1 1 GLY A 21 ASN A 44 1 24 HELIX 2 2 ASP A 46 SER A 75 1 30 HELIX 3 3 ALA A 76 ASN A 96 1 21 HELIX 4 4 ASP A 97 ILE A 119 1 23 HELIX 5 5 GLY B 21 ASN B 44 1 24 HELIX 6 6 ASP B 46 ASN B 96 1 51 HELIX 7 7 ASP B 97 SER B 121 1 25 LINK C LEU A 25 N MSE A 26 1555 1555 1.32 LINK C MSE A 26 N LEU A 27 1555 1555 1.33 LINK C ASP A 46 N MSE A 47 1555 1555 1.33 LINK C MSE A 47 N GLU A 48 1555 1555 1.33 LINK C SER A 77 N MSE A 78 1555 1555 1.33 LINK C MSE A 78 N GLY A 79 1555 1555 1.33 LINK C ALA A 80 N MSE A 81 1555 1555 1.33 LINK C MSE A 81 N TYR A 82 1555 1555 1.33 LINK C TYR A 84 N MSE A 85 1555 1555 1.33 LINK C MSE A 85 N TYR A 86 1555 1555 1.33 LINK C GLY A 99 N MSE A 100 1555 1555 1.33 LINK C MSE A 100 N LEU A 101 1555 1555 1.33 LINK C LEU B 25 N MSE B 26 1555 1555 1.32 LINK C MSE B 26 N LEU B 27 1555 1555 1.33 LINK C ASP B 46 N MSE B 47 1555 1555 1.33 LINK C MSE B 47 N GLU B 48 1555 1555 1.33 LINK C SER B 77 N MSE B 78 1555 1555 1.33 LINK C MSE B 78 N GLY B 79 1555 1555 1.33 LINK C ALA B 80 N MSE B 81 1555 1555 1.33 LINK C MSE B 81 N TYR B 82 1555 1555 1.33 LINK C TYR B 84 N MSE B 85 1555 1555 1.33 LINK C MSE B 85 N TYR B 86 1555 1555 1.33 LINK C GLY B 99 N MSE B 100 1555 1555 1.33 LINK C MSE B 100 N LEU B 101 1555 1555 1.33 CRYST1 53.968 64.151 68.561 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018529 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015588 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014586 0.00000